3-(4-Methoxy-benzylsulfanyl)-3-methyl-butyric acid

3-(4-Methoxy-benzylsulfanyl)-3-methyl-butyric acid is a non-proteinogenic, sulfur-containing amino acid derivative featuring a branched aliphatic backbone bearing a carboxylic acid and a primary amino group, along with a 3-methyl substitution and a thioether substituent linked to a 4-methoxybenzyl group. The side chain contains a sulfanyl (thioether) linkage that provides a soft sulfur donor for thioether-based conjugation or coordination chemistry, while the aromatic ring bears a para-methoxy substituent that modulates polarity and electronic character; stereochemistry is not specified in the name. In synthetic and chemical biology contexts, this molecule is used as a precursor for preparing modified amino acid building blocks and peptides where a thioether-functional side chain is required for structure-activity studies, bioconjugation handle installation, or downstream derivatization to more reactive sulfur-containing functionalities.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP26922

CAS No:268219-99-4

Synonyms/Alias:3-(4-METHOXY-BENZYLSULFANYL)-3-METHYL-BUTYRICACID;268219-99-4;SCHEMBL8746111;CTK4F8566;ZINC2560758;5197AH;AKOS025404110;AK186609;OR250760;K-6884;S-(4-METHOXYBENZYL)-DEAMINO-PENICILLAMINE

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C13H18O3S
M.W/Mr.
254.35

3-(4-Methoxy-benzylsulfanyl)-3-methyl-butyric acid is a sulfur-containing, non-proteinogenic amino acid derivative featuring a thioether side chain and a branched, methyl-substituted backbone. Its carboxylic acid functionality makes it a practical building block for downstream synthesis of peptidomimetic and medicinal chemistry scaffolds where controlled hydrophobicity and thioether incorporation are required. The aromatic methoxybenzyl sulfanyl motif provides a stable sulfur handle that is routinely leveraged in structure-activity relationship (SAR) studies and intermediate diversification workflows.

1. Peptidomimetic Building Blocks

3-(4-Methoxy-benzylsulfanyl)-3-methyl-butyric acid is used by medicinal chemistry and peptide-mimetic research groups to construct side-chain-defined analogs that emulate amino acid substitution patterns while introducing a thioether-bearing aromatic group. In custom peptide and peptidomimetic assembly programs, the carboxylic acid serves as a reliable functional group for conversion into activated coupling partners or incorporation into larger fragments, enabling systematic variation of sterics and lipophilicity around a branched backbone. This derivative is particularly valued when the target scaffold design benefits from a stable thioether substituent rather than a more labile sulfur functionality.

2. Pharmaceutical Intermediate Diversification

3-(4-Methoxy-benzylsulfanyl)-3-methyl-butyric acid supports pharmaceutical intermediate development where a protected, side-chain-bearing amino acid derivative is needed for iterative synthesis. Process and synthesis teams commonly incorporate this compound as a defined sulfur-containing intermediate to access analog series with consistent stereochemical and connectivity features, facilitating parallel library synthesis for SAR and lead optimization. The methoxybenzyl sulfanyl group provides a chemically stable handle for further downstream transformations in medicinal chemistry routes, while the carboxylic acid enables straightforward progression to coupling-ready forms used in multi-step intermediate sequences.

3. Structure-Activity Relationship Studies

3-(4-Methoxy-benzylsulfanyl)-3-methyl-butyric acid is frequently selected for SAR studies that probe how thioether substitution and aromatic methoxybenzyl character influence potency-related properties in small-molecule and peptidomimetic candidates. Research groups use it to generate analogs that vary sulfur-containing side-chain volume and electronic character while keeping the backbone substitution pattern consistent through the branched 3-methyl motif. This makes the compound useful in iterative design cycles where chemists need a structurally specific, sulfur-bearing building block to map structure-property relationships across closely related series.

4. Chiral Intermediate Development

3-(4-Methoxy-benzylsulfanyl)-3-methyl-butyric acid is also applied in chiral synthesis workflows where amino acid-derived fragments are used to access enantiomerically defined intermediates for downstream stereochemical control. Synthetic chemistry teams can leverage the amino acid-like carboxylic acid functionality and the side-chain-defined thioether/aromatic motif to build stereochemically constrained intermediates for subsequent fragment coupling or scaffold elaboration. This use case is common in programs that require consistent stereochemical outcomes across a series of sulfur-containing analogs, including peptidomimetic and medicinal chemistry targets.

Size
1 g;5 g;
InChI
1S/C13H18O3S/c1-13(2,8-12(14)15)17-9-10-4-6-11(16-3)7-5-10/h4-7H,8-9H2,1-3H3,(H,14,15)
InChI Key
VLSLXZFZXHZCHI-UHFFFAOYSA-N
Canonical SMILES
CC(C)(CC(=O)O)SCC1=CC=C(C=C1)OC

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServiceEpitope Mapping ServicesPeptide Nucleic Acids SynthesisPeptide CDMOPeptide Synthesis ServicesPeptide Analysis ServicesCustom Conjugation ServicePeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers